All posts tagged james degregori

  • Molecularly targeted therapies hold promise for many pediatric cancers, but at what cost? Image: Flickr/Cliff1066

    Lancet Oncology: Long-term side-effects of new, targeted therapies in pediatric cancer patients

    A University of Colorado Cancer Center review published this week in the journal Lancet Oncology describes possible long-term side-effects of new, targeted therapies in pediatric cancer patients: what we don’t know may hurt us.

Cancer-Catching Net
Changing tissue landscape and not necessarily accumulated oncogenic mutations drives higher cancer rates in the elderly. Image: Mick Jagger, cc license.
James DeGregori, Team In Training
Chemotherapy pushes AML cancer cells toward a corner -- the protein WEE1 helps them brake to stay on track. Take away WEE1 and AML cells hit the wall. (Photo courtesy of Flickr user ShinyThings, cc license.)
Cancer cells are like prarie dogs -- when a first-line cancer drug plugs the front dooor, cancer cells evolve to find other escapes. Photo courtesy of Flickr user gripso_banana_prune, CC license.
DeGregori
DeGregori